| Peptide-mediated protein delivery—Which pathways are penetrable? H Räägel, P Säälik, M Pooga Biochimica et Biophysica Acta (BBA)-Biomembranes 1798 (12), 2240-2248, 2010 | 109 | 2010 |
| CPP–protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway H Räägel, P Säälik, M Hansen, Ü Langel, M Pooga Journal of Controlled Release 139 (2), 108-117, 2009 | 58 | 2009 |
| Retro-inversion of certain cell-penetrating peptides causes severe cellular toxicity T Holm, H Räägel, SEL Andaloussi, M Hein, M Mäe, M Pooga, Ü Langel Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (6), 1544-1551, 2011 | 41 | 2011 |
| Multiple faces of cell-penetrating peptides–their intracellular trafficking, stability and endosomal escape during protein transduction H Räägel | 35 | 2011 |
| Cell-penetrating peptide secures an efficient endosomal escape of an intact cargo upon a brief photo-induction H Räägel, M Hein, A Kriiska, P Säälik, A Florén, Ü Langel, M Pooga Cellular and molecular life sciences 70, 4825-4839, 2013 | 24 | 2013 |
| Adenosine–oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton H Räägel, M Lust, A Uri, M Pooga The FEBS Journal 275 (14), 3608-3624, 2008 | 22 | 2008 |
| Mapping of protein transduction pathways with fluorescent microscopy H Räägel, P Säälik, Ü Langel, M Pooga Cell-Penetrating Peptides: Methods and Protocols, 165-179, 2011 | 5 | 2011 |
| Peptide and protein delivery with cell-penetrating peptides H Räägel, M Pooga Peptide and Protein Delivery, 221-246, 2011 | 4 | 2011 |
| ÔØ Å ÒÙ× Ö ÔØ H Räägel, P Säälik, M Hansen, U Langel, M Pooga | | 2009 |
| Bisubstraatne inhibiitor ARC surub efektiivselt maha Rho-kinaasist lähtuvaid signaaliradasid rakukultuuris H Räägel | | 2007 |
Matthew R. JorgensenNelson LaboratoriesVerified email at nelsonlabs.com
